News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,806 Results
Type
Article (14156)
Company Profile (282)
Press Release (251368)
Section
Business (79516)
Career Advice (153)
Deals (13228)
Drug Delivery (35)
Drug Development (50424)
Employer Resources (31)
FDA (5713)
Job Trends (5128)
News (144391)
Policy (10032)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (909)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21626)
ALS (57)
Alzheimer's disease (813)
Antibody-drug conjugate (ADC) (79)
Approvals (5720)
Artificial intelligence (103)
Autoimmune disease (8)
Automation (5)
Bankruptcy (104)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (38)
Biotechnology (232)
Bladder cancer (40)
Brain cancer (19)
Breast cancer (135)
Cancer (1192)
Cardiovascular disease (95)
Career advice (132)
Career pathing (2)
CAR-T (102)
Cell therapy (295)
Cervical cancer (5)
Clinical research (40742)
Collaboration (477)
Compensation (206)
Complete response letters (13)
COVID-19 (1031)
CRISPR (35)
C-suite (131)
Cystic fibrosis (75)
Data (1242)
Denatured (11)
Depression (28)
Diabetes (114)
Diagnostics (1288)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (75)
Drug pricing (27)
Drug shortages (3)
Duchenne muscular dystrophy (66)
Earnings (29470)
Editorial (16)
Employer branding (4)
Employer resources (29)
Events (47954)
Executive appointments (384)
FDA (6278)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (440)
Gene editing (84)
Generative AI (9)
Gene therapy (219)
GLP-1 (345)
Government (1075)
Grass and pollen (2)
Guidances (18)
Healthcare (6589)
Huntington's disease (21)
IgA nephropathy (19)
Immunology and inflammation (73)
Indications (17)
Infectious disease (1087)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (16)
Intellectual property (52)
Interviews (17)
IPO (7259)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (198)
Leadership (2)
Legal (1385)
Liver cancer (30)
Lung cancer (169)
Lymphoma (79)
Machine learning (1)
Management (7)
Manufacturing (110)
MASH (46)
Medical device (2603)
Medtech (2604)
Mergers & acquisitions (6236)
Metabolic disorders (345)
Multiple sclerosis (48)
NASH (13)
Neurodegenerative disease (53)
Neuropsychiatric disorders (22)
Neuroscience (1162)
NextGen: Class of 2025 (2014)
Non-profit (852)
Northern California (1449)
Now hiring (21)
Obesity (181)
Opinion (99)
Ovarian cancer (50)
Pain (39)
Pancreatic cancer (49)
Parkinson's disease (99)
Partnered (6)
Patents (101)
Patient recruitment (60)
Peanut (35)
People (25456)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14383)
Phase II (18952)
Phase III (11982)
Pipeline (604)
Podcasts (43)
Policy (34)
Postmarket research (852)
Preclinical (6020)
Press Release (30)
Prostate cancer (50)
Psychedelics (35)
Radiopharmaceuticals (210)
Rare diseases (265)
Real estate (1414)
Recruiting (12)
Regulatory (8513)
Reports (14)
Research institute (936)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (85)
Series B (53)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1290)
Special edition (11)
Sponsored (11)
Startups (1970)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (32)
United States (11460)
Vaccines (198)
Venture capitalists (27)
Webinars (7)
Weight loss (101)
Women's health (14)
Worklife (2)
Date
Last 7 days (340)
Last 30 days (1572)
Last 365 days (20081)
2025 (3850)
2024 (20556)
2023 (22419)
2022 (26841)
2021 (27819)
2020 (23363)
2019 (16225)
2018 (11762)
2017 (13759)
2016 (11859)
2015 (14358)
2014 (10393)
2013 (7484)
2012 (7533)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (37)
Alaska (2)
Arizona (50)
Arkansas (5)
Asia (17176)
Australia (2914)
California (3317)
Canada (1019)
China (294)
Colorado (127)
Connecticut (141)
Delaware (84)
Europe (36933)
Florida (386)
Georgia (99)
Idaho (16)
Illinois (202)
India (7)
Indiana (83)
Iowa (1)
Japan (65)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (428)
Massachusetts (2619)
Michigan (69)
Minnesota (129)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (14)
New Hampshire (13)
New Jersey (834)
New Mexico (12)
New York (911)
North Carolina (502)
North Dakota (4)
Northern California (1449)
Ohio (102)
Oklahoma (8)
Oregon (21)
Pennsylvania (632)
Puerto Rico (2)
Rhode Island (13)
South America (207)
South Carolina (3)
Southern California (1290)
Tennessee (24)
Texas (372)
Utah (47)
Virginia (66)
Washington D.C. (27)
Washington State (308)
Wisconsin (13)
265,806 Results for "renova therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced current and potential future clinical directions that can expand the use of its gene therapies to treat additional debilitating diseases.
June 12, 2024
·
4 min read
Biotech Beach
Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene therapies on two primary regulatory pathways as key value drivers.
May 8, 2024
·
5 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Cardiovascular disease
Deep Dive: Cardiovascular Disease Back in the Spotlight
In this deep dive,
BioSpace
explores the diverse therapeutic modalities now in development, as well as the opportunities and battles for market dominance in this emerging space.
March 10, 2025
·
2 min read
·
Heather McKenzie
Layoffs
Repare Therapeutics to Cut Staff Again, This Time by 75%
The latest Repare Therapeutics layoffs will include its chief medical officer and could leave the biotech with fewer than 35 employees as it works to advance two Phase I clinical programs.
February 25, 2025
·
2 min read
·
Angela Gabriel
BlueWind Medical Reaches 100th Patient for the OASIS Study of the RENOVA™ iStim System
BlueWind Medical announces its 100th patient implant in their pivotal study for treating overactive bladder symptoms using an innovative medical device the RENOVA™ iStim.
July 6, 2021
·
3 min read
Gene therapy
5 Cardio Gene Therapies on the Near Horizon
Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic for cardiovascular diseases including congestive heart failure, chronic refractory angina and cardiomyopathy.
January 13, 2025
·
9 min read
·
Tristan Manalac
Genetown
Laborie Introduces the Next Generation RenovaRP Centesis System
Laborie Medical Technologies, Inc., a leading diagnostic and therapeutic medical technology company, is proud to announce the launch of the RenovaRP™ Centesis System, an innovative fluid drainage device designed to advance patient care and improve efficiency for healthcare professionals.
January 8, 2024
·
2 min read
Press Releases
Allogene Therapeutics Announces Participation in March Investor Conference
February 26, 2025
·
2 min read
Press Releases
YourChoice Therapeutics Announces Nature Publication
March 13, 2025
·
4 min read
1 of 26,581
Next
